Package 70436-113-82

Brand: cisatracurium besylate

Generic: cisatracurium besylate
NDC Package

Package Facts

Identity

Package NDC 70436-113-82
Digits Only 7043611382
Product NDC 70436-113
Description

10 VIAL, SINGLE-DOSE in 1 CARTON (70436-113-82) / 10 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2023-12-01
Brand cisatracurium besylate
Generic cisatracurium besylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "14793b7b-0e90-7b75-e063-6394a90a9c5a", "openfda": {"unii": ["80YS8O1MBS"], "rxcui": ["199211"], "spl_set_id": ["e06c4d57-bfc7-45ad-b1cd-b5b88dc43b50"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (70436-113-82)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70436-113-82", "marketing_start_date": "20231201"}], "brand_name": "Cisatracurium besylate", "product_id": "70436-113_14793b7b-0e90-7b75-e063-6394a90a9c5a", "dosage_form": "INJECTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "70436-113", "generic_name": "Cisatracurium besylate", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "2 mg/mL"}], "application_number": "ANDA216538", "marketing_category": "ANDA", "marketing_start_date": "20231201", "listing_expiration_date": "20261231"}